Skip to main content

PPD Launches CRA Apprenticeships for Vets with Medical Backgrounds

Wilmington-based contract research organization Pharmaceutical Product Development (PPD) has launched a clinical research associates apprenticeship program targeted at military veterans with medical backgrounds.

Vote today for RTP’s UVision360 Hysteroscopy Systems

RTP's UVision 360 has been chosen by Medical Device and Diagnostic Industry (MD+DI), a print and online magazine, to participate in its annual Medtech Startup Showdown. North Carolina's life science and technology community can ensure one of our own makes it to Round 2 by voting now.

Humacyte Vessel Gets Special FDA Review Designation

Humacyte, a Research Triangle Park-based biotechnology company focused on regenerative medicine, has won one of the first Regenerative Medicine Advanced Therapy (RMAT) designations from the U.S. Food and Drug Administration

Finalists Named in Inaugural SoBran/NCBiotech Life Science Research Prize Competition

Five research scientists from four North Carolina universities are finalists in the inaugural Innovation for Impact Prize competition, co-sponsored by SoBran Bioscience and the Piedmont Triad Office of the North Carolina Biotechnology Center.

TransEnterix Robotic System Proving Value in Hernia Repair

TransEnterix, a Morrisville medical device company that uses robotics to improve minimally invasive surgery, has expanded the clinical adoption of its Senhance Robotic Surgical System to include a full range of hernia repairs.

Positive Early Phase 2 Lung Cancer Data Buoy Heat Bio

Heat Biologics (Nasdaq:HTBX) has reported early positive results in a Phase 2 trial of its immunotherapy lung cancer treatment.

Durham's Qualyst Launches New Test for Avoiding Liver Toxicity

Durham-based Qualyst Transporter Systems (QTS) has launched a new test that can steer drug developers away from compounds that could cause liver damage.

Bioventus Commissions New Clinical Tests of Ultrasound Bone Healing System

Bioventus, a Durham-based orthobiologics company, says it will commission a series of clinical studies to further validate the ability of its EXOGEN Ultrasound Bone Healing System to lessen the risk of a fracture not healing properly in the presence of known risk factors.


Subscribe to RSS - Business & Commercialization